- Home
- GIGM vs IMNN Comparison
GIGM vs IMNN Comparison
Compare GIGM & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIGM
- IMNN
- Stock Information
- Founded
- GIGM 1998
- IMNN 1982
- Country
- GIGM Taiwan
- IMNN United States
- Employees
- GIGM N/A
- IMNN N/A
- Industry
- GIGM Computer Software: Programming Data Processing
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- GIGM Technology
- IMNN Health Care
- Exchange
- GIGM Nasdaq
- IMNN Nasdaq
- Market Cap
- GIGM 17.9M
- IMNN 12.1M
- IPO Year
- GIGM 2000
- IMNN 1985
- Fundamental
- Price
- GIGM $1.45
- IMNN $0.80
- Analyst Decision
- GIGM
- IMNN Buy
- Analyst Count
- GIGM 0
- IMNN 2
- Target Price
- GIGM N/A
- IMNN $14.00
- AVG Volume (30 Days)
- GIGM 29.7K
- IMNN 2.6M
- Earning Date
- GIGM 07-30-2025
- IMNN 08-13-2025
- Dividend Yield
- GIGM N/A
- IMNN N/A
- EPS Growth
- GIGM N/A
- IMNN N/A
- EPS
- GIGM N/A
- IMNN N/A
- Revenue
- GIGM $3,103,000.00
- IMNN N/A
- Revenue This Year
- GIGM N/A
- IMNN N/A
- Revenue Next Year
- GIGM N/A
- IMNN N/A
- P/E Ratio
- GIGM N/A
- IMNN N/A
- Revenue Growth
- GIGM N/A
- IMNN N/A
- 52 Week Low
- GIGM $1.26
- IMNN $0.37
- 52 Week High
- GIGM $1.80
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- GIGM 50.64
- IMNN 41.12
- Support Level
- GIGM $1.41
- IMNN $0.70
- Resistance Level
- GIGM $1.45
- IMNN $0.86
- Average True Range (ATR)
- GIGM 0.05
- IMNN 0.10
- MACD
- GIGM 0.00
- IMNN -0.06
- Stochastic Oscillator
- GIGM 25.00
- IMNN 10.31
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).